Keyphrases
Clinical Trials
100%
Drug Development
100%
Risk Outcomes
100%
Patient Outcomes
100%
Patient Benefit
100%
Risk-benefit
100%
Patient Risk
100%
Ramucirumab
100%
Approved Indication
50%
FDA-approved Drugs
37%
Adverse Events
25%
Overall Survival
25%
Literature Search
12%
Evidence-based
12%
Randomized Controlled Trial
12%
PubMed
12%
MEDLINE
12%
Embase
12%
Poor Survival
12%
Monotherapy
12%
Medical Decision Making
12%
Cochrane
12%
Positive Outcomes
12%
Survival Benefit
12%
Progression-free Survival
12%
Cancer Treatment
12%
Trial Participants
12%
Efficacy Outcomes
12%
Oncology Drugs
12%
Screening Data
12%
Data Screening
12%
Gastric Cancer
12%
Failure Rate
12%
Clinical Trial Failures
12%
Off-label Indications
12%
Excess Burden
12%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Drug Development
100%
Ramucirumab
100%
Adverse Event
25%
Malignant Neoplasm
25%
Overall Survival
25%
Randomized Controlled Trial
12%
Monotherapy
12%
Progression Free Survival
12%
Abdominal Cancer
12%
Medicine and Dentistry
Clinical Trial
100%
Ramucirumab
100%
Adverse Event
25%
Overall Survival
25%
Randomized Controlled Trial
12%
Malignant Neoplasm
12%
Clinician
12%
Medical Decision Making
12%
Progression Free Survival
12%
Cancer Therapy
12%
Monotherapy
12%
Abdominal Cancer
12%